Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 150

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 18
Chunk 150
---
                                                                          
●   On June 27, 2024, 62,500,000 options were issued to the Group’s employees based under the Company’s 2018 American Depositary Share (ADS) Option Plan. The options are exercisable at US$0.0031 (A$0.0046) and expire on March 13, 2029. The fair value of the options is A$0.0037 per option.               
●   On June 27, 2024, 120,000,000 options were issued to the Group’s key management personnel based under the Company’s 2018 American Depositary Share (ADS) Option Plan. The options are exercisable at US$0.003 (A$0.0044) and expire on March 21, 2029. The fair value of the options is A$0.0037 per option.
F-28

ALTERITY THERAPEUTICS LIMITED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – in Australian dollars (unless otherwise noted)

11. RESERVES (continued)

(c) Movements in Options for Fully Paid Ordinary Shares (continued)

Year ended June 30, 2025:
   
●                                                                                  On August 1, 2024, 12,000,000 options expired.                                                                               
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
●   On August 31, 2024, 1,935,759,704 options expired.                                                                                                                                                          
●   On December 30, 2024, 170,000,000 options were issued to the Group’s directors as per resolutions passed at the AGM in November 2024. The options are exercisable at A$0.01 and expire on December 30, 2027.
●   On January 22, 2025, 95,238 options were exercised.                                                                                                                                                         
●   On January 30, 2025, 6,333,333 options were exercised.                                                                                                                                                      
●   On January 4, 2022, 14,000,000 options were forfeited upon resignation of two Non-Executive Directors.                                                                                                      
●   On March 14, 2025, 161 options were exercised.                                                                                                                                                              
●   On April 23, 2025, 1,222,300,911 free-attaching options were issued                                                                                                                                         
    as per the securities placement plan. The options are exercisable at A$0.028 and expire on February 26,